NCT06710366View on ClinicalTrials.gov

Prevalence of DAO (diamino Oxidase) Deficiency in Newborns

CompletedOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

February 28, 2023

Primary Completion Date

June 21, 2024

Study Completion Date

June 26, 2024

Conditions
DAO Genetic Variants
Trial Locations (1)

08195

Hospital General de Catalunya, Sant Cugat del Vallès

Sponsors

Lead Sponsor

AB Biotek
All Listed Sponsors
collaborator

Grupo Hospitalario Quironsalud-Catalunya

UNKNOWN

collaborator

Hospital Universitari General de Catalunya

OTHER

collaborator

Quironsalud

OTHER

lead

AB Biotek

INDUSTRY

NCT06710366 - Prevalence of DAO (diamino Oxidase) Deficiency in Newborns | Biotech Hunter | Biotech Hunter